Which entities were involved in the INBP share transfers?

Shares were transferred from CD Financial, LLC and the Carl DeSantis Revocable Trust to CDDS 2.0, LLC. CDDS 2.0, LLC is described as a Florida limited liability company controlled by Damon DeSantis, consolidating these indirect holdings under that entity.

[Form 4] INTEGRATED BIOPHARMA INC Insider Trading Activity

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Integrated BioPharma director and 10% owner Damon DeSantis reported two bona fide gift transfers of Common Stock involving related entities. The filing shows gifts of 8,966,547 and 2,235,417 shares, for a total of 11,201,964 shares, at a stated price of $0 per share.

According to the footnotes, these shares were transferred from CD Financial, LLC and the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by DeSantis. After these transfers, DeSantis indirectly holds 12,733,058 shares of Integrated BioPharma Common Stock through CDDS 2.0, LLC.

Insider Trade Summary

11,201,964 shares gifted

Mixed 2 txns

Insider DeSantis Damon

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Gift	Common Stock	8,966,547	$0.00	--
Gift	Common Stock	2,235,417	$0.00	--

Holdings After Transaction: Common Stock — 10,497,641 shares (Indirect, By CDDS 2.0, LLC)

Footnotes (1)

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person. Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Key Figures

First gift transfer: 8,966,547 shares Second gift transfer: 2,235,417 shares Total gifted shares: 11,201,964 shares +3 more

6 metrics

First gift transfer 8,966,547 shares Common Stock gifted on April 15, 2026 from CD Financial, LLC

Second gift transfer 2,235,417 shares Common Stock gifted on April 15, 2026 from Carl DeSantis Revocable Trust

Total gifted shares 11,201,964 shares Aggregate bona fide gifts reported in this Form 4

Post-transaction holdings 12,733,058 shares Common Stock indirectly held via CDDS 2.0, LLC after transfers

Intermediate holding figure 10,497,641 shares Common Stock indirectly held following the first reported gift

Gift price per share $0.00 per share Stated transaction price for each bona fide gift of Common Stock

Key Terms

bona fide gift, indirect ownership, Common Stock, Form 4, +1 more

5 terms

bona fide gift financial

"transaction_code_description": "Bona fide gift""

indirect ownership financial

""direct_or_indirect": "I", "ownership_type": "indirect""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

CDDS 2.0, LLC financial

"to CDDS 2.0, LLC, a Florida limited liability company controlled"

Form 4 Insider Transactions: What Each Field Means →

04/17/2026 - 11:21 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeSantis Damon

(Last)

(First)

(Middle)

109 SE 5TH AVENUE

SECOND FLOOR

(Street)

DELRAY BEACH

FLORIDA

33483

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRATED BIOPHARMA INC [ INBP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/15/2026		G⁽¹⁾		8,966,547	A	$0	10,497,641	I	By CDDS 2.0, LLC
Common Stock	04/15/2026		G⁽²⁾		2,235,417	A	$0	12,733,058	I	By CDDS 2.0, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

2. Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

	/s/ Damon DeSantis	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Damon DeSantis report for INBP?

Damon DeSantis reported two bona fide gift transfers of Integrated BioPharma Common Stock between related entities, totaling 11,201,964 shares. These non-cash transactions reorganized indirect holdings through CDDS 2.0, LLC, a Florida limited liability company controlled by him.

How many Integrated BioPharma (INBP) shares were transferred in the gifts?

The reported gifts involved 8,966,547 shares and 2,235,417 shares of Integrated BioPharma Common Stock, for a combined total of 11,201,964 shares. Both transactions were recorded at a price of $0.00 per share as bona fide gifts.

Were the INBP transactions market sales or non-cash gifts?

The transactions were non-cash bona fide gifts, not market sales or purchases. Both were coded as “G” on Form 4, with a transaction price per share of $0.00, indicating disposals by gift rather than open-market trading activity.

How many INBP shares does Damon DeSantis hold after these transactions?

After the reported transfers, Damon DeSantis indirectly holds 12,733,058 shares of Integrated BioPharma Common Stock through CDDS 2.0, LLC. This post-transaction figure reflects his indirect ownership as shown in the Form 4 filing.

What is CDDS 2.0, LLC’s role in Damon DeSantis’s INBP holdings?

CDDS 2.0, LLC is a Florida limited liability company controlled by Damon DeSantis that now holds gifted Integrated BioPharma shares. Following the reported transfers, it is the entity through which DeSantis indirectly owns 12,733,058 shares of the company’s Common Stock.